199

7. REFERENCES

1. Ahmed. A. E, Howida. K. I and Balquees. S. H., Formulation and evaluation of colon

targeted tablets containing Simvastatin solid dispersion, Drugs and Therapy Studies .,

1, 62-67, 2011.

2. Ahmed. A. E, Howida. K. I and Balquees. S. H., Understanding the formulation

variables of orodispersible tablets containing Simvastatin solid dispersion using Box-

Behnken design, Jo u r na l o f Drugs and Therapy Studies, 2, 29-35,2012.

3. Akbari. B. V , Valaki. B. P , Maradiya. V . H and Akbari. A. K .G., Development and

evaluation of orodispersible tablets of rosuvastatin Calcium-hp-β-cd inclusion

complex by using different superdisintegrants, International Journal of Pharmacy

and Technology., 3, 1842-1859, 2011.

4. Amidon. G. L, Lennernas. H, Shah. V . P and Crison. J.R., Theoritical basis for a

biopharmaceutical drug classification: the correlation of in vivo bioavailability,

Pharm. Res., 413-420, 1995.

5. Anshuman. A. A, Mahadik. K. R and Anant. P ., Spray-dried amorphous solid

dispersions of Simvastatin, a low tg drug: in vitro and in vivo evaluations, Journal of

Pharmaceutical Research., 22 , 990-998, 2005.

6. Arambulo. A. S and Deardroff. D. L., Determination of particle size of powders by

sieiving, J. Am. Pharm. Assoc., 42, 690-695, 1953.

7. Arunachalam. A, Karthikeyan. K, Kishore. K, Hari prasad. P , Sethuraman. S and

Ashutoshkumar. S, Solid Dispersions: A review, Current. Pharm. Research., 1, 82-

90, 2010.

8. Ashis Kumar. M, Vidyadhara. S, Ramu. A, Abhijit. D and Sambat. L.,

Physicochemical characterization and improvement of dissolution rate of Lovastatin

by solid dispersions, Inventi Impact:Pharm. Tech., 2, 15-17, 2012.

200

9. Ashok. R. P and Pradeep R. V ., Preparation and in vivo evaluation of self-micro

emulsifying drug delivery system containing Fenofibrate, AAPS Pharm. Sci. Tech, 9,

344-352, 2007.

10. Badry. M. E, Fetih. G and Fathy. M., Improvement of solubility and dissolution rate

of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000, Saudi. Pharm.

J., 17, 217– 225, 2009.

11. Balaji. N, Sai Kishore.V and Hari Krishna, K., Formulation and evaluation of

Simvastatin solid dispersions for dissolution rate enhancement, Research Journal of

Pharmaceutical., Dosage Forms and Technology.,3, 152-157, 2011.

12. Balaji. S and Sumitha. A., Development and validation of spectrophotometric method

for determination of Simvastatin in tablet formulation, Pak. J. Pharm. Sci., 23, 375-

378, 2010.

13. Bernard. V . E, Michiel. V . S, Raf. M, Kristof. H, Johan. A. M and Ludo. F.,

Itraconazole TPGS aerosil200 solid dispersions characterization physical stability and

in vivo performance, Eur. J. Pharm. Sci., 38, 270-278, 2009.

14. Bhanubhai. N. S, Haresh. M. P , Shailesh. A. S, Ishwarnish. R and Vijay. KP.,

Preparation and characterization of etoricoxib polyethylene glycol 4000 plus poly

vinyl pyrrolidone K30 solid dispersions, Acta. Pharm., 56, 285-298, 2006.

15. Bhumika. P , Parikh. R. H and Deepali. S., Enhancement of dissolution of telmisartan

through use of solid dispersion technique surface solid dispersion, Journal of

Pharmacy and Bioallied sciences ., 4, 64-68, 2012.

16. Bi. Y . X, Sunanda. H, Yonezawa. Y and Danjo. K., Evaluation of rapidly

disintegrating tablets prepared by a direct compression method, Drug Dev. Ind.

Pharm., 25, 571–581, 1999.

17. Bindu Madhavi. B, Kusum. B, Ramalingam. R, Ravinder Nath.A, Zulkar Nain K,

Arjun. G and David. B., Preparation, characterization, and tableting of a solid

201

dispersion of Simvastatin with super disintegrants, Journal of Pharmacy Research., 3,

2568-2570, 2010.

18. Botozolakis. J. E and Augsburger. L. L., Disintegrating agents in hard gelatin

capsules Part I:Mechanism of action, Drug. Dev. Ind. Pharm., 14, 29-41, 1988.

19. Breitenbach. J., Melt extrusion: form process to drug delivery technology, Eur. J.

Pharm. Biopharm., 54, 107-117, 2002.

20. Breitenbach. J., Melt extrusion: form process to drug delivery technology, Eur. J.

Pharm. Biopharm., 54, 107-11, 2002.

21. Bruno. C. H and Micheal. P ., The true solubility advantage for amorphous

pharmaceuticals, Pharmaceutical Research., 17, 397-404, 2000.

22. Chiou. W. L and Riegelman. S., Increased dissolution rates of water insoluble cardiac

glycosides and steroids via solid dispersions in PEG-6000, J. Pharm. Sci., 60, 1569-

1571, 1971.

23. Chiou. W. L and Riegelman. S., Pharmaceutical applications of solid dispersion

systems, J. Pharm. Sci., 60, 1281-1302, 1971.

24. Chiou. W. L, S and Riegelman. S, Preparation and dissolution characteristics of

several fast-release solid dispersions of griseofulvin, J. Pharm. Sci., 58, 1505-1510,

1969.

25. Chiou.W. L and Riegelman. S., Oral absorption of griseofulvin in dogs: increased

absorption via solid dispersion in polyethylene glycol 6000, J. Pharm. Sci., 57, 937-

941,1970.

26. Chong. P . H., Clinically relevant differences between the statins: implications for

therapeutic selection, Am. J. Med., 111, 390-400, 2001.

202

27. Cilurzo. F, Minghetti. P , Cariraghi. A and montanari L., Charecterization of nifidipine

solid dispersions, Int. J. Pharm., 242, 313-317, 2002.

28. Corrigan. O. J, Morphy, C. A and Timoney. R. F., Dissolution properties of

polyethylene glycol-drug systems, Int. J. Pharm., 4, 67-74, 1979.

29. Craig. D. Q. M.,. The mechanisms of drug release from solid dispersions in water-

soluble polymers, Int. J. Pharm., 231, 131-144, 2002.

30. Curran. M. P and Goa. K. L., Lovastatin extended release: a review of its use in the

management of hpercholesteromia, Drugs., 63, 685-699, 2003.

31. Dahinder. LE, Johansson. M and Siogren. S., Determination of flow properties, J,

Drug. Dev. Ind. Pharm, 8, 455-457, 1982.

32. Debjit. B, Chiranjib. B, Jithendra. Y, Chandira. R. M and Sampath Kumar. K. P .,

Emerging trends of disintegrants used in the formulation of solid dosage form,

Scholars Research Library., 2, 495-504, 2010.

33. Desager. J. P and Horsmans. Y ., Clinical pharmacokinetics of 3-hydroxy-3-

methylglutaryl- coenzyme A reductase inhibitors, Clin Pharmacokinetic., 31, 348-

371, 1996.

34. Desai. J, Alexander. K and Riga. A., Characterization of polymeric dispersions of

Dimenhydrinate in ethyl cellulose for controlled release, Int. J. Pharmaceutics., 308,

115-123, 2006.

35. Dipika. M, Probir Kumar. O, Bankim Chandra. N and Lakshmi Kanta. G., Effect of

carriers on solid dispersions of Simvastatin (sim): physico-chemical characterizations

and dissolution studies, Scholars Research Library., 2, 47-56, 2010.

36. Direndra. K, Lewis. S, Udupa. N and Atin K., Solid dispersions an overview, Pak. J.

Pharm. sci., 22, 234-246, 2009.

203

37. DirkJan. V ., Marine spray freeze-drying to produce a stable 9-tetrahydrocannabinol

containing inulin based solid dispersion powder suitable for inhalation, Eur. J. Pharm.

Biopharm., 231-240, 2005.

38. Dixit. R. P and Nagarsenker. M. S., In vitro and in vivo advantage of celecoxib

surface solid dispersion and dosage form development, Indian journal of

pharmaceutical sciences ., 69, 370-377, 2007.

39. Dokoumetzidis. A, Papadopoulou. V , Valsami. G and Macheras. P ., Development of

a reaction-limited model of dissolution: Application to official dissolution tests

experiments, Intl. J. Pharmaceutics., 355, 114-125, 2008.

40. Duncan Q. M. C., The mechanisms of drug release from solid dispersions in water-

soluble polymer, Intl. J. Pharmaceutics., 231, 131-144, 2001.

41. Errikson. H. J. C, Hinrichs. W. L. J, Vanreen. B, Somsen. G. W, Dejong. G. J and

Frijlink. H. W., Investigations into the stabilization of drugs by sugar glasses: I.

Tablets prepared from stabilized alkaline phosphatase, Int. J. Pharm., 249, 59-70,

2002.

42. Fernandez. M, Rodriguez. I. C, Margarit. M. V and Cerezo. A., Charecterization of

solid dispersions of piroxicam/ PEG 4000, Int. J. Pharm., 84, 197-202, 1992.

43. Fincher. JH., Particle size of drugs and its relationship to absorption and activity, J.

Pharm. Sci., 57, 1825-1835, 1968.

44. Ford. J. L., Physical dissolution and formulation properties of solid dispersions,

Liverpool, Liverpool Polytechnic., 5th ed 1-10, 1980.

45. Ford. J. L., The influence of polyethylene glycol molecular weight variation on the

properties of gluterthimide-PEG solid dispersions, Pharm. Acta. Helv., 59, 280-288,

1984.

204

46. Forster. A, Hempenstall. J, Tucker. I and Rades. T., Selection of excipients for melt

extrusion with two poorly water soluble drugs by solubility by solubility parameter

calculation and thermal analysis, Int. J. Pharm., 226, 147-161, 2001.

47. Froemming. K. H, Simons. B, Haase. J and Hosemann. R., Problems of preparation,

processing and storage of melt embeeded PEG products, Pharm. Ind., 40, 967-970,

1978.

48. Fujji. M, Terai. H, Mori. T, Sweda. Y and Matsumotu. M., The properties of solid

dispersions of indomethacin, ketprofen and flurbiprofen in phosphatidyl choline,

Chem. Pharm. Bull., 36, 2186- 2192, 1987.

49. Ganesh. C, Piyush. P , Sharwaree. H, Mukul. K, Ashok. B and Sagar. B., Formulation

and evaluation of solid dispersions of furosemide in sodium starch glycolate, Trop. J.

Pharm. Res., 8, 43-51, 2009.

50. Garala Kevin. C., Fast-disintegrating aceclofenac tablets: formulation development

using simplex lattice design, Thai J. Pharm. Sci., 32, 77-81, 2008.

51. Gebremariam. T ., Evaluation of the disintegrantion efficiency of SSG prepared from

enset starch in compressed tablets, Eur. J. Pharm. Biopharm., 42, 124-132, 1996.

52. Geneidi. A. S, Ali. A. A and Salma. R. B., Solid dispersions of nitrofurantoin,

ethotoin and coumarin with polyethylene glycol6000 and their coprecipitates with

povidone 25,000, J. Pharm. Sci., 67, 114-116, 1978.

53. Ghaderi. R, Artursson. P and Carfors. J., Preparation of biodegradable micro particles

using solution enhanced dispersion by super critical fluids, Pharm. Res., 16, 676-681,

1999.

54. Ghaderi. R, Artursson. P and Carifors. J., Preparation of biodegradable microparticles

using solution enhanced dispersion by supercritical fluids (SEDS), Pharm. Res., 16,

676-681,1999.

205

55. Gissinger. D and Stamm. A., A comparative evaluation of the properties of some

tablet disintegrants, Drug. Dev. Ind. Pharm., 6, 511-536, 1980.

56. Gold berg. A. H, Gibaldi. M and Kanig. J. L., Increasing dissolution rate and gastro

intestinal absorption of drugs via solid solutions and eutectic mixtures. II.

Experimental evaluation of eutectic mixture: Urea- Acetaminpphen system, J. Pharm.

Sci., 55, 482- 487, 1966.

57. Gold berg. A. H, Gibaldi. M, and Kanig. J.L., Increasing dissolution rate and gastro

intestinal absorption of drugs via solid solutions and eutectic mixtures. II.

Experimental evaluation of griseofulvin- Succinic acid solution, J. Pharm. Sci., 55,

487-492, 1966.

58. Gold berg. A.H, Gibaldi. M, Kanig. J. L. Increasing dissolution rate and gastro

intestinal absorption of drugs via solid solutions and eutectic mixtures. I. Theoretical

considerations and discussion of the literature, J. Pharm. Sci., 55, 1145-1148, 1965.

59. Goldberg. A. H, Gibaldi. M and Kanig. J. L., Increasing dissolution rates and

gastrointestinal absorption of drugs via solid solutions and eutectic mixtures III-

experimental evaluation of griseofulvin -succinic acid solid solution, J. Pharm. Sci.,

55, 487-492, 1966.

60. Hadi. V , Ali. N, Nahid. Q, Parvin. Z. M, Shirzad. A, Davood. H and Raimar. L.,

Physicochemical characterization of solid dispersions of indomethacin with PEG

6000, myrj 52, lactose, sorbitol, dextrin, and eudragit e100, Drug Development and

Industrial Pharmacy., 30, 303-317, 2004.

61. Haibeng. H, Rui. Y and Xin. T., In vitro and in vivo evaluation of fenofibrate solid

dispersion prepared by hot melt extrusion, Drug. Dev. Ind. Pharm., 36, 681-687,

2010.

62. Hannula. A. M., Release of ibuprofen from hard gelatin capsule formulations: effect

of modern disintegrants, Acta..Pharm.Fenn., 98, 189-196, 1989.

206

63. Harwood. R.J and Johnson. J. L., Hydroxypropylmethylcellulose, in: A. Wade, P .J.

Weller Handbook of Pharmaceutical Excipients, American Pharmaceutical

Association/The Pharmaceutical Press, Washington, DC/London, 229-232, 1994.

64. Hasegawa. R, Kawamura. R, Nakagawa. H and Sugimoto. I., Physical properties of

solid dispersions of poorly water-soluble drugs with enteric coating agents, Chem.

Pharm. Bull., 33, 3429-3435, 1985.

65. Heike. B, Bernd. F and Roland. B., Characterization and stability of solid dispersions

based on PEG polymer blends, Int. J. Pharm., 390, 165-173, 2010.

66. Hem. S. L, Skauen. D. M and Beal. H. M., Mechanism of crystallization of

hydrocortisone by ultrasonic irradiation., J. Pharm. Sci., 56, 229-233, 1967.

67. Hipasawa. S., Application of Nilvadipine solid dispersion to tablet formulation and

manufacturing using crospovidone and methyl cellulose on dispersion carriers, Chem,

Pharm.Bull., 52, 244-247, 2004.

68. Ho Ho. H. L, Shu. H. L, Tsai. T and Sheu. M. T., The preparation and

characterization of solid dispersion on pellets using a fluidized bed system, Int. J.

Pharm., 139, 223-229, 1996.

69. Hume rotherly. N and Paynor. G. V , The structure of metals and alloys., Institute of

metals London., 1, 3, 1954.

70. Islam. U. K, Tayyaba. K, Ashfaq. M and Sharif. F., Development and validation of

Liquid chromatographic method for simultaneous estimation of ezitemibe and

Lovastatin in human plasma, J. Chil. Chem. Soc., 55, 1-6, 2010.

71. Jafar. M, Wehghan. M and Shareef. A., Enhancement of dissolution and anti-

inflammatory effect of meloxicam, Int. J. App. Pharmaceutics ., 2, 231-238, 2010.

72. Jagawa. M., Effect of various disintegrants on drug release behaviour from tablets, J.

Pharm. Sci. Tech, 63, 238-248, 2003.

207

73. Jagdale. S. C, Patil. S. A, Kuchekar. B. S and Chabukswar. A. R., Preparation and

characterization of metformin hydrochloride — compritol 888 ato solid dispersion,

Journal of young pharmacists ., 3, 197-204, 2011.

74. Jeevana Jyothi. B and Suneela. G., Development of fast dissolving tablets of

glibenclamide using crospovidone and its kneading mixture, Indian J. Pharm. Educ.

Res., 44, 334-340, 2010.

75. Kai. T, Akiyama. Y , Nomura. S and Sato. M., Oral absorption improvement of poorly

soluble drug using solid dispersion technique, Chem. Pharm. Bull., 44, 568-571,

1996.

76. Kang. B. K, Lee. J. S, Chan. S. K, Jeong. S. Y and Yuk. S. H., Development of self

microemulsifying drug delivery systems for oral bioavailability enhancement of

Simvastatin in beagle dogs, Int. J. Pharm., 274, 65-73, 2004.

77. Kanig. J. L., Properties of fused mannitol in compressed tablets, J.Pharm. Sci., 53,

188- 92, 1964.

78. Kedzierewicz. F, Villieras. F, Zinutti. C, Hoffman. M and Maincet. P ., A 3 year

stability study of tolbutamide solid dispersions and 13-cyclodextrin complex, Int.

J.Pharm., 117, 247-251, 1995.

79. Khayyam. S. K , Shailesh. P , Santosh. P and John. D. S., Dissolution and stability

enhancement of poorly water soluble drug – Lovastatin by preparing solid

dispersions, Asian Journal of Biomedical and Pharmaceutical Sciences ., 1, 24-

31,2011.

80. Khoo. S. M, Porter. C. J. H and Charman. W. N. The formulation of Halofantrine as

eithernon-solubilising PEG 6000 or solubilising lipid based solid dispersions:

Physical stability and absolute bioavailability assessment, Int. J. Pharm., 205, 65–78,

2000.

208

81. Kim. E, Chun. M, Jang. J, Lee. I, Lee. K and Choi. H., Preparation of a solid

dispersion of felodipine using a solvent wetting method,. Eur. J. Pharm. Biopharm.,

64, 200- 205, 2006.

82. Komal. R. P , Sunny. R. S and Navin. R., Studies in dissolution enhancement of

ezetimibe by solid dispersions incombination with a surface adsorbent, Dissolution

Technologies.,8, 58-61, 2011.

83. Kompella. U. B and Koushik. K., Precipitation of drug delivery systems using super

fluid technology, Crit.Rev. Ther . Drug carrier Syst., 18, 173-199, 2001.

84. Kornblum. S. S and Hirschor. J. O., Dissolution of poorly water soluble drugs. I.

some physical parameters related to method of micronization and tablet manufacture

of a quinazolinone compound, J. Pharm. Sci., 59, 606-609, 1970.

85. Kristyn. G and Theodore. L. B., Design and characterization of a laminar flow-

through dissolution apparatus: Comparison of hydrodynamic conditions to those of

common dissolution techniques, Pharmaceutical development and Technology ., 16,

75-87,2011.

86. Kumar Katare. M, Kohli. S and Pal Jain. A., Evaluation of dissolution enhancement

of Lovastatin by solid dispersion technique, Int. J. of Pharm. and Life Sci ., 2, 894-

898, 2011.

87. Lachman. L and Liberman.H. A., Theory and Practice of industrial pharmacy,

Varghese Publishing House., 2nd edition, 293, 1998.

88. Langenbucher.F., Linearization of dissolution rate curves by the Weibull distribution,

J.Pharm.Phrmacol., 24, 979-81, 1972.

89. Law. S. L , Lowy. S, Lin. F. M and Chaing. C. H., Dissolution and absorption of

nifidipine in polyethylene glycol solid dispersions containing phosphatidylcholine,

Int. J. Pharm., 84,161-166, 1922.

209

90. Lennernas. H and Fager. G., Pharmacodynamics and Pharmacokinetics of the HMG-

CoA reductase inhibitors; similarities and differences, Clin Pharmacokinetic., 32,

403-425 1997.

91. Lennernas. Ha nd Fager. G., Pharmacodynamics and Pharmacokinetics of the HMG-

CoA reductase inhibitors: similarities and differences, Clin Pharmacokinet., 32, 403-

425, 1997.

92. Leuner. C and Dressman. J., Improving drug solubility for oral delivery using solid

dispersion, Eur. J. Pharm. BioPharm., 50, 47-60, 2000.

93. Levy. G., Effect of particle size on dissolution and gastrointestinal absorption rates of

pharmaceuticals, Amer. J. Pharm., 135, 78-92, 1963.

94. Lipinski. C. A., Avoiding investment in doomed drugs is poor solubility an industry

wide problem, Curr . Drug. Dis., 4, 17-19, 2001.

95. Madhuri. N, Krishna. H. B, Dong. X. L, Jung. H. S, Jung. A. K and Bong. K. Y .,

Enhanced dissolution of ibuprofen using solid dispersion with polyethylene glycol

20000, Drug. Dev. Ind. Pharm., 34, 1013-1021, 2008.

96. Madhuri. N, Krishna. H. B, Jung. A. K, Bong. K.Y , Han. G. C and Chul. S. Y .,

Preparation and evaluation of fast dissolving ibuprofen polyethylene glycol 6000 solid

dispersions, Drug. Deliv. J., 15, 355-364, 2008.

97. Makiko. F, Hideko. O, Yusuke .S, Honami. T, Masuo. K and Yoshiteru. W.,

Preparation, characterization, and tableting of a solid dispersion of indomethacin with

crospovidone, International Journal of Pharmaceutics ., 293, 145-153, 2005.

98. Mandhere. K. S., Tabletting properties of directly compressible starch, J. Pharm.

Sci.,58, 616-620, 1969.Marishita. M., Combined water soluble carriers for

coprecipitaes of tolbutamide, J. Pharm. Sci., 71, 301-304,1 982.

210

99. Markus. V , Klaus. K and Jennifer B.D., Dissolution enhancement of fenofibrate by

co-grinding and spray drying: Comparision with the commercial preparations,

European Journal of Pharmaceutics and Biopharmaceutics ., 68, 83- 288, 2008.

100. Maron. D. J., Current Perspectives on statins, Circulation., 101, 207-213, 2000.

101. Maryadele. J, and Neil. O, The Merck Index, Merck research labs., 14, 5585, 2006.

102. Mauro. V . F ., Clinical pharmacokinetics and practical applications of Simvastatin,

Clin. Pharmacokinetic., 24, 195-202, 1993.

103. Mehardad. H, Najmeh. Z and Mohammad ali. S., A simple and sensitive HPLC

method for quantitation of Lovastatin in human plasma: Application to a

bioequivalence study, Biol. Pharm. Bull., 32, 1600-1603, 2009.

104. Milani. P . Z, Nezhadi. S. H, Jalali. M. B, Mohammadi. L, Nokhodch. I and

Valizadeh. H.,Studies on dissolution enhancement of prednisolone, a poorly water-

soluble drug bysolid dispersion technique, Adv. Pharm. Bull., 1, 48-53, 2011.

105. Miralles. M. J, Mcginty. J. W and Martin. A., Combined water soluble carriers for

coprecipitates of tolbutamide, J. Pharm. Sci., 71, 302-304, 1982.

106. Modi. P and Tayade. H.K., A comparitive enhancement profile of valdecoxib with

different solubilization approaches, Ind. J. Pharm. Sci ., 69, 274-278, 2007.

107. Mohanraj. P and Jasmina. K., Solid dispersion of prednisolone: solid state

characterization and improvement of dissolution profile, Drug. Dev. Ind. Pharm., 3,

1-15, 2010.

108. Mohl. S and Winter. G., Continuous release of rh-interferon alpha-2a from

triglyceride matrices, J. Control Release., 97,67-68,2004.

109. Moneghini. M, Carcano. A, Zingone. G and Perissutti. B., Studies in dissolution

enhancement of atenolol, Int. J. Pharm., 175, 177- 183, 1998.

211

110. Monica. R, Yogesh. M, Kaushik. T and Sucheta. B., Dissolution improvement of

simvastatin by surface solid dispersion technology, Journal of Dissolution

Technologies., 6, 27-34, 2010.

111. Moreshwar. P . P and Naresh. J. G., Preparation and characterization of gliclazide

polyethylene glycol 4000 solid dispersions, Acta. Pharm., 59, 57-65, 2009.

112. Mura. P , Faucci. M.T, Manderioli. A, Bramanti. G and Parrini. P ., Thermal behavior

and dissolution properties of naproxen from binary and ternary solid dispersions,

Drug Dev. Ind. Pharm., 25, 257-264, 1999.

113. Murali Mohan Babu. G. V ., In Vivo Evaluation of modified gum karaya as a carrier

for Improving the Oral Bioavailability of a Poorly Water-Soluble Drug, nimodipine.,

AAPS Pharm. Sci.Tech, 3, 245-247, 2002.

114. Narmada. G.Y., Formulation evaluation and optimization of fast dissolving tablets

containing amlodipine besylate by sublimation method, Ars. Pharm., 50, 129-144,

2009.

115. Nernst. W., Theorie der reaktinogeschwindigkeit in heterogenen systemen,

ZeitscriftF. Physik Chemie., 47, 52-55, 1904.

116. Neumann. B.S., Flow properties of disperse systems, Interscience Academic

presss., 1, 10-15, 1953.

117. Nivaldo. L.S and Renata. B.O., Preparation and charecterization of solid

dispersions of Simvastatin, Journal of Drug Development and Industrial Pharmacy .,

36, 11-16, 2010.

118. Nogami. H., Nagai.T and Kondo. A., Dissolution kinetics of PVP, Chem. Pharm.

Bull., 1185-1190, 1970.

212

119. Noyes. A. A and Whitney. W. R., The rate of solution of solid substances in their

own solutions., J. Am. Chem. Soc., 19, 930-934, 1897.

120. Okhamafe. A. O and York. P , Moisture permeation mechanism of aqueous based

film coats, J. Pharm. Pharmcol., 34, 53, 1982.

121. Okonogi. S, Oguchi. T, Yonemochi. E, Puttipipatkhachorn. S and Yamamoto. K.,

Improved dissolution of Ofloxacin via solid dispersion, Int. J. Pharm., 156, 175-180,

1997.

122. Pai. G. S., Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and

biochemical observations on twelve patients, Mol Genet Metab., 69, 312-322, 2000.

123. Patel. D. M, Shah. R. R and Jogani. P . D., Tablet formulation of piroxicam

containing polyvinyl pyrrolidone K- 30 and sodium lauryl sulphate, Indian J. Pharm.

Sci., 66, 49-55, 2004.

124. Patel. M, Tekad.e M, Gattani. S and Surana. S., Solubility enhancement of

Lovastatin by modified locust bean gum using solid dispersion techniques, AAPS.

Pharm.Sci.Tech., 9, 9171-9174, 2008.

125. Patel. M. M and Patel. D. M., Fast dissolving valdecoxib tablets containing solid

dispersion of valdecoxib, Indian. J. Pharm. Sci ., 68, 222- 226, 2006.

126. Patel. R. P and Patel. M. M., Physicochemical Characterization and Dissolution

Study of Solid Dispersions of Lovastatin with Polyethylene Glycol-4000 and

Polyvinylpyrrolidone-K30, Pharmaceutical Development and Technology ., 12, 21-

33, 2007.

127. Patidar. K., Solid Dispersion: Approaches, technology involved, Unmet need and

challenges., Drug Invention Today, 2, 349-357, 2010.

213

128. Patil. P , Moreshwar. M and Pandharinath.H., Characterization of gliclazide-

polyethylene glycolsolid dispersion and its effect on dissolution, Brazilian Journal of

Pharmaceutical Sciences, 34, 1931-1938, 2011.

129. Perissuti. B, Newton. J. M, Podezeck. F, Rubessa. F., Preparation of extruded

carbamazepine and PEG4000 as a potential rapid release dosage form, Eur. J. Pharm.

Biopharm., 53, 125-132, 2002.

130. Pinnamaneni. N. G, Das. N. G and Das. S. K., Formulation approaches for orally

administered poorly soluble drugs, Pharmazie., 57, 291-300, 2002.

131. Pokharkar. V .B, Leenata. P .M, Mahesh. N.P, Anshuman. A, Kakasaheb. R.M and

Anant. P , Development charecterization and stabilization of amorphous form of a low

Tg drug, Powder Technol., 167, 20-25, 2006.

132. Porter. C. J. H, Charman. S. A, Williams. R. W, Bakalova. M. V and Charman W.

N., Evaluation of emulsifiable glasses for the oral administration of cyclosporine in

beagle dogs, Int. J. Pharm,141, 227-237, 1996.

133. Pouton. C. N., Formulation of poorly water soluble drugs for oral administration:

Physicochemical and Physiological issues and the lipid formulation classification

systems, Eur. J. Pharm. Sci., 29, 278-287, 2006.

134. Prajapati. S. T, Gohel. M. C and Patel. L. D., Studies to enhance dissolution

properties of carbamazepine, Ind. J. Pharm. Sci ., 69, 427-430, 2007.

13 5. Punitha. S and Senthil Kumar. K. L., .Evaluation of solubility of Simvastatin using

β-cyclodextrin by solid dispersion technique, International Journal of Biomedical

Research., 1-6 , 2 010 .

136. Rakesh. P and Madhabhai P ., Preparation, Characterization, and dissolution

behaviour of a solid dispersion of Simvastatin with polyethylene glycol 4000 and

polyvinylpyrrolidoneK30, Journal of Dispersion Science and Technology ., 29, 193-

204, 2008.

214

137. Rastogi. R. P and Ramavarma K. T., Solid-liquid equilibria in solutions of

nonelectrolytes, J. Chem. Soc., 2, 2097-2101, 1956.

138. Reedhill. R. E., Physical metallurgy principles, Van-Nostrand, Prince town, NJ,

255, 1964.

139. Renata. J and Anna. C., Preparation and evaluation of piroxicam HPMCAS solid

dispersions for ocular use, Pharm. Dev. Tech., 13, 495-504, 2008.

140. Riikka. L, Eero. S, Mikko. B, Joakim. R, Vesa-Pekka. L and Kristiina. J. J. K.,

Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability

and formulation, Brazilian Journal of Pharmaceutical Sciences ., 36, 601-613, 2010.

141. Ritthidej. G. C, Yonemochi. E, Oguchi. T and Yamamoto. K., Effect of water-

soluble carriers on dissolution characteristics of nifedipine solid dispersions, Drug

Development and Industrial Pharmacy ., 26, 1141-1150, 2000.

142. Rudni. L., Evaluation of mechanism of disintegrant action, Drug. Dev. Ind.

Pharm.,8, 87-109, 1982.

143. Sarkari. M, Brow. J, Chen. X, Swinnea. S and Williams. RO., Enhanced drug

dissolution using evaporative precipitation into aqueous solution., Int. J. Pharm., 243,

17-31, 2002.

144. Schectman. G and Hiatt. J, Dose-response characteristics of cholesterol lowering

drug therapies: implications for the treatment, Ann Intern Med., 125, 990-1000, 1996.

145. Scheikh. M. A, Price. J. C and Gerraughty. R. T., Effect of ultra sound on particle

size of suspensions of polyethylene spheres, J. Pharm. Sc.i, 55, 1048-1050, 1966.

146. Schiemeier. S and Schmidt. P . C, Fast dispersible ibuprofen tablets, Eur. J. Pharm.

Sci., 15, 295-305, 2002.

215

147. Sean. C. S and Martindale., The complete drug reference, Pharmaceutical Press.,

34, 997- 999, 2005.

148. Sekiguchi. K and Obi. N., Studies on absorption of eutectic mixtures I. A

comparision of the behaviour of eutectic mixture of sulphathiazole in man, Chem.

Pharm. Bull., 9, 866-872, 961.

149. Sekikana. H, Nakano. M, and Arita. T., Dissolution mechanisms of drug polyvinyl

pyrrolidone coprecipitates in aqueous solutions, Chem. Pharma. Bull., 27, 1223-

1230, 1979.

150. Sekikawa. H, Nakano.M and Avita.T., Inhibitory effect of PVP on the

crystallization of drugs, Chem. Pharm. Bull., 26, 118-126, 1978.

151. Serajuddin. A. T. M, Sheen P . C and Augustine. M. A., Improved dissolution of a

poorly water soluble drug from solid dispersions in polyethylene glycol:

polysorbate80 mixture, J. Pharm. Sci., 79, 463-464, 1990.

152. Sethia. S and Squillante. E., Physicochemical charecterization of solid dispersions

of carbamazepine formulated by super critical carbondioxide and conventional

solvent evaporation method, J. Pharm. Sci., 91, 1948-1957, 2002.

153. Shah. J. C, Chen. J. R and Chow. D., Preformulation study of etoposide: II.

Increased solubility and dissolution rate by solid-solid dispersions, Int. J. Pharm.,

113, 103-111, 1995.

154. Shavi. G. V , Averineni. R. K, Usha. Y . K, Armugam. K, Ranjan. O. P and

Ginjupalli. K. Enhanced dissolution and bioavailability of gliclazide using solid

dispersion techniques, Int J. Drug. Delivery., 2, 49-57, 2010.

155. Sheen. P . C, Khetarpal. V . K, Caroila. C. M and Rowlings. C. E., Formulation

studies of a poorly water soluble drug in solid dispersions to improve bioavailabilty,

Int. J. Pharm., 118, 221-227, 1998.

216

156. Sheetal. M, Supriya. S, and Kadam. V . J., Formulation and evaluation of

oxacarbazepine fast dissolve tablets, Indian J. Pharm. Sci., 69, 211-214, 2007.

157. Simonelli. A. P , Mehta. S. C and Higuchi. W. I., Dissolution rates of high energy

poly vinyl pyrrolidone- sulfathiazole coprecipitates, J. Pharm. Sci.,58, 538-549,

1969.

158. Singh. A, Sharma. P . K, Meher. J.G and Malviya. R., Evaluation of enhancement of

solubility of Paracetamol by solid dispersion technique using different polymers

concentration, Asian J. Pharmaceutical and clin. Res ., 4, 117-119, 2011.

159. Singla. A.K and Vijayan. T., Dissolution of sulfamethoxazole from polyethylene

glycols and PVP solid dispersions, Drug. Dev. Ind. Pharm., 16, 875-882, 1990.

160. Skauen. D. M., Some pharmaceutical applications of ultrasonics, J. Pharm. Sci., 56,

1373 -1385, 1967.

161. Snopal. R. N, Lalwani. A. N, Vinay. C. D and Kaushik. R. P ., Solid dispersion: an

efficient tool for increasing bioavailability of poorly soluble drugs, International

Journal of Pharmaceutical Sciences Review and Research , 8, 37-52, 2011.

162. Soniwala. M. M, Patel. P . R, Mansuri. N. S, Parik. R. K and Gohel. M. C., Various

approaches in dissolution enhancement of rofecoxib, Indian J. Pharm. Sci ., 67, 61-

65, 2005.

163. Srinivas. M, Parambil. A, Krishnan. M and Achuta. N. U, Enhancement of

dissolution rate and bioavailability of aceclofenac: A chitosan based solvent change

approach, Int. J. Pharm, 350, 279-290, 2008.

164. Streubel. A, Siepmann. J and Bodmeier. R., Drug delivery to the upper small

intestine window using gastro retentive technologies, Current Opinion in

Pharmacology., 6, 501-508, 2006.

217

165. Subramaniam. B, Rajewski. R. A and Snavely. K,. Pharmaceutical processing with

supercritical carbon dioxide, J. Pharm. Sci., 86, 885-890,1997.

166. Sugwara. M, Kadomura. S, Xin. H, Takekuma. Y , Kohri. N and Miyazaki. K., The

use of in vitro dissolution and absorption system to evaluate oral absorption of two

weak bases in pH-Independent controlled-release formulations, European. J.

Pharmaceutical Sci., 26, 1-8, 2005.

167. Sunita. A, Tejal. A. M and Ankit. B., Formulation, Development and evaluation of

fast disintegrating tablets of rizatriptan benzoate using novel adjuvants, Int.J. Chem.

Tech. Res., 2, 1026-1030, 2010.

168. Suzuki. H and Sunanda. H., Influence of water-soluble polymers on the dissolution

of nifedipine solid dispersions with combined carriers, Chem. Pharm. Bull., 46, 482-

487, 1998.

169. Swati. R and Jain. S. K., Enhancement of intestinal absorption of few Cox-2

inhibitors through interaction with β-cyclodextrin, Indian. J. Pharm. Sci ., 69, 529-

534, 2007.

170. Taizia. D. S, Valquiria. T. A, Jackson. A. L. C. R, Nivaldo. L. S, Renata. B. O and

Cristina D. V . S., Preparation and characterization of solid dispersion of Simvastatin,

Drug. Dev. Ind. Pharm., 36, 1348-1355, 2010.

171. Taylor.L. S and Zografi. G., Spectroscopic characterization of interactions between

PVP and indomethacin in amorphous molecular dispersions, Pharm. Res., 14, 1691-

1698, 1997.

172. Tripathi. M, Kohoil. D. V and Uppadhyay. R. K., Enhancement of solubility and

dissolution of indomethacine and phenyl butazone by cholic and deoxycholic acid

conjugates, Drug. Dev. Ind. Pharm., 18, 135-141, 1992.

218

173. Urbanetz. N. A and Lippold. B. C., Solid dispersions of nimodipine and

polyethylene glycol 2000: dissolution properties and physico-chemical

characterization, Eur. J. Pharm. Biopharm., 59, 107–118, 2005.

174. Van Drooge. D. J, Hinrichs. W. L. J and Frijlink. H. W., Anomalous dissolution

behaviour of tablets prepared from sugar glass-based solid dispersions., J.

Controlled. Release., 2, 64-78, 2004.

175. Vasconelos. T and Sarmento. B., Solid dispersions as a strategy to improve the

bioavailability poorly water soluble drugs, Drug. Dis. Today., 12, 1068-1075, 2007.

176. Vidyadhara. S, Ramana reddy. G. V ., Ramu. A and Chandana. P ., Formulation and

evaluation of Lovastatin fast dissolving tablets using newer super disintegrants,

Journal of Pharmacy Research, 4, 25-28, 2011.

177. Vijay Kumar. S. G and Mishra. D. N., Preparation, characterization and in vitro

dissolution studies of solid dispersion of meloxicam with PEG 6000, Journal of the

Pharmaceutical Society of Japan ., 126, 657-664, 2006.

178. V ora. N and Rana. V ., Preparation and optimization of mouth/orally dissolving

tablets using a combination of glycine, carboxymethyl cellulose and sodium alginate:

a comparison with superdisintegrants., Pharm. Dev. Technol., 13(3), 233- 43, 2008.

179. Wamian. F, Blafon. N, Kinget. R and Vandenmooter. G., Physical stability of solid

dispersions of the antiviral agent UC-78 with PEG6000, gelucire44/14 and PVPK30,

Int. J. Pharm., 244, 87-98, 2002.

180. White. C. M., Pharmacological effects of HMG CoA reductase inhibitors other than

lipoprotein modulation, J Clin. Pharmacol., 39, 111-118, 1999.

181. Wiggam. M. I and Beringer. T. R. O., Effect of low molecular weight: heparin on

serum concentrations of potassium, Lancet., 350, 292-293, 1997.

219

182. Wilcox. W. R, Friedenberg. R and Back. N., Zone melting of organic compounds,

Chem. Pev., 64, 187-220, 1964.

183. Williams. D and Feely. J, Pharmacokinetic-Pharmacodynamic drug interactions

with HMG- Co A reductase inhibitors, Clin Pharmacokinetic., 41, 343-370, 2002.

184. Yang. H. T, Feng. Y and Luan. Y . W, Determination of Simvastatin in human

plasma by liquid chromatography, J. Chormatogr., 785, 369-375, 2003.

185. Yuasa. H, Ozeki. T, Takahashi. H, Kanaya. Y and Ueno. M., Application of the

solid dispersion method to the controlled release of medicine, Chemical

pharmaceutical bulletin ., 41, 933-936, 1993.

186. Zerrouk. N, Chemtob. C, Arnaud. P , Toscani. S and Dugue. J., In vitro and in vivo

evaluation of carbamazepine-PEG 6000 solid dispersions, Int. J. Pharm., 225, 49–

62, 2001.